Supplementary Table 1.docx (23.5 kB)

Supplementary Table 1. Optimal First-Line Immune Checkpoint Inhibitor Treatment in Lung Cancer: How to Choose?

dataset

posted on 2022-01-12, 10:44 authored by Baskoro Kartolo, Andrew Robinson, Andrea S. Fung

ICI-Related Phase III RCTs in Previously Untreated Advanced NSCLC without Driver Mutations

Funding

N/A

History

Usage metrics

Future Oncology

Categories

Keywords

Non-small-cell lung cancer Metastatic First-line therapy Immunotherapy Chemotherapy Cancer Therapy (excl. Chemotherapy and Radiation Therapy)Molecular Targets Solid Tumours

Licence

CC BY-NC-ND 4.0

Exports